VANCOUVER, BC – (GLOBE NEWSWIRE) – November 23, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a non-exclusive, pilot supplier distribution agreement in Canada between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company, with respect to the handheld

VANCOUVER, BC – (GLOBE NEWSWIRE) – October 27, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces that it has expanded patient testing with the HealthTab™ platform in select Shoppers Drug Mart® pharmacies in British Columbia, bringing its diabetes screening program to Western Canada for the first time. “The launch

VANCOUVER, BC – (GLOBE NEWSWIRE) –  September 13, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces that it has appointed Oak Hill Financial Services Inc. (“Oak Hill”) to provide the Company with investor relations and advisory services. Oak Hill is a Toronto-based financial services company that assists companies in

VANCOUVER, BC – (GLOBE NEWSWIRE) –August 10, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces that patient testing has begun on the HealthTab™ platform in select Shoppers Drug Mart® pharmacies.   The participating Shoppers Drug Mart® pharmacies have now received their HealthTab™ systems and will begin offering screening tests

VANCOUVER, BC – (GLOBE NEWSWIRE) – July 28, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a partnership agreement with Ellerca Health Corp to utilize their respective technologies and services to offer the most robust diabetes screening and management solutions on

VANCOUVER, BC – (GLOBE NEWSWIRE) – July 26, 2021 – Avricore Health Inc. (TSXV:AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first amendment to its supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company and

VANCOUVER, BRITISH COLUMBIA – July 19, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company”; or “AVCR”) announces that patient testing has begun on the first deployment of the new HealthTab™-integrated Afinion 2™ analyzers in the initial Shoppers Drug Mart® pharmacy location as part of its previously announced effort to

VANCOUVER, BRITISH COLUMBIA – June 30, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is hosting the first of a regular series of investor calls hosted by the Company’s CEO and key team members to provide progress updates and take questions.  “We have many enthusiastic supporters, and

VANCOUVER, BRITISH COLUMBIA – June 29, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces it has successfully launched HealthTab™ in the first of 11 Shoppers Drug Mart pilot locations. The rollout is part of its recently announced Master Agreement and Statement of Work.  Under the agreement,